Peak Bio, Inc.
PKBO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -0.4% | – | -1,518.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -0.3% | – | -1,569.7% |
| EPS Diluted | -0.021 | -0 | -0.74 | -0.48 |
| % Growth | -48,933.3% | 100% | -54.2% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | $0 | -$0 | -$0 |
| Free Cash Flow | – | -$0 | -$0 | -$0 |